Alzheimer's Research & Therapy, 1758-9193

Tidskrift

Fler filtreringsmöjligheter
  1. 2019
  2. Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

    Oskar Hansson, Lehmann, S., Otto, M., Zetterberg, H. & Lewczuk, P., 2019 apr 22, I : Alzheimer's Research and Therapy. 11, 1, s. 1-15 15 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  3. 2018
  4. Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele

    Van Loenhoud, A. C., Groot, C., Vogel, J. W., Van Der Flier, W. M. & Rik Ossenkoppele, 2018 sep 11, I : Alzheimer's Research and Therapy. 10, 1, 91.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  5. Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: A 22-year follow-up study

    Thordardottir, S., Rodriguez-Vieitez, E., Almkvist, O., Ferreira, D., Saint-Aubert, L., Kinhult-Ståhlbom, A., Thonberg, H., Michael Schöll, Westman, E., Wall, A., Eriksdotter, M., Zetterberg, H., Blennow, K., Nordberg, A. & Graff, C., 2018 maj 10, I : Alzheimer's Research and Therapy. 10, 1, 45.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease

    Patra, K., Soosaipillai, A., Sando, S. B., Lauridsen, C., Berge, G., Møller, I., Grøntvedt, G. R., Bråthen, G., Begcevic, I., Moussaud, S., Lennart Minthon, Oskar Hansson, Diamandis, E. P., White, L. R. & Nielsen, H. M., 2018, I : Alzheimer's Research and Therapy. 10, 1, 9.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. 2017
  8. Cerebrovascular and amyloid pathology in predementia stages: The relationship with neurodegeneration and cognitive decline

    Bos, I., Verhey, F. R., Ramakers, I. H. G. B., Jacobs, H. I. L., Soininen, H., Freund-Levi, Y., Hampel, H., Tsolaki, M., Åsa K. Wallin, Van Buchem, M. A., Oleksik, A., Verbeek, M. M., Olde Rikkert, M., Van Der Flier, W. M., Scheltens, P., Aalten, P., Visser, P. J. & Vos, S. J. B., 2017 dec 29, I : Alzheimer's Research and Therapy. 9, 1, 101.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations

    Lautner, R., Philip S. Insel, Skillbäck, T., Olsson, B., Landén, M., Frisoni, G. B., Herukka, S-K., Hampel, H., Wallin, A., Lennart Minthon, Oskar Hansson, Blennow, K., Niklas Mattsson & Zetterberg, H., 2017 okt 23, I : Alzheimer's Research and Therapy. 9, 1, 87.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  10. Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)

    Vanderstichele, H., Demeyer, L., Shorena Janelidze, Coart, E., Stoops, E., Mauroo, K., Herbst, V., François, C. & Oskar Hansson, 2017 jun 6, I : Alzheimer's Research and Therapy. 9, 1, 40.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  11. 2016
  12. The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease

    Öhrfelt, A., Brinkmalm, A., Dumurgier, J., Brinkmalm, G., Oskar Hansson, Zetterberg, H., Bouaziz-Amar, E., Hugon, J., Paquet, C. & Blennow, K., 2016 okt 3, I : Alzheimer's Research & Therapy. 8, 1, 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  13. Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease

    Henjum, K., Almdahl, I. S., Årskog, V., Lennart Minthon, Oskar Hansson, Fladby, T. & Nilsson, L. N. G., 2016, I : Alzheimer's Research & Therapy. 8, 1, 182.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. 2015
  15. Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls

    Kvartsberg, H., Portelius, E., Andreasson, U., Brinkmalm, G., Hellwig, K., Lelental, N., Kornhuber, J., Oskar Hansson, Lennart Minthon, Spitzer, P., Maler, J. M., Zetterberg, H., Blennow, K. & Lewczuk, P., 2015, I : Alzheimer's Research & Therapy. 7, 1, 40.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review.

    Jekel, K., Damian, M., Wattmo, C., Hausner, L., Bullock, R., Connelly, P. J., Dubois, B., Eriksdotter, M., Ewers, M., Graessel, E., Kramberger, M. G., Law, E., Mecocci, P., Molinuevo, J. L., Nygård, L., Olde-Rikkert, M. G., Orgogozo, J-M., Pasquier, F., Peres, K., Salmon, E. & 6 andraSikkes, S. A., Sobow, T., Spiegel, R., Tsolaki, M., Winblad, B. & Frölich, L., 2015, I : Alzheimer's Research & Therapy. 7, 1, 17.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  17. 2014
  18. Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.

    Oskar Hansson, Sara Hall, Ohrfelt, A., Zetterberg, H., Blennow, K., Lennart Minthon, Katarina Nägga, Elisabet Londos, Varghese, S., Majbour, N. K., Al-Hayani, A. & El-Agnaf, O. M., 2014, I : Alzheimer's Research & Therapy. 6, 3, 25.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2013
  20. Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application

    Carina Wattmo, Jedenius, E., Blennow, K. & Åsa Wallin, 2013, I : Alzheimer's Research & Therapy. 5, 1, 2.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Plasma tau levels in Alzheimer's disease

    Zetterberg, H., Wilson, D., Andreasson, U., Lennart Minthon, Blennow, K., Randall, J. & Oskar Hansson, 2013, I : Alzheimer's Research & Therapy. 5, 2, 9.

    Forskningsoutput: TidskriftsbidragLetter